Octapharma announces that the final results from the phase III ProDERM study will be presented at the American College of Rheumatology (ACR) Convergence 2020 virtual ... Nov 07
Novartis Cosentyx shows early synovitis reduction in patients with psoriatic arthritis in the first-of-its-kind study... Nov 05
-Advertisements-